Molecular diagnosis and immunotherapy
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Purpose of review: To describe recent insights into how molecular diagnosis can improve indication and selection of suitable allergens for specific immunotherapy and increase the safety of this therapy. Recent findings: As specific allergen immunotherapy targets specific allergens, identification of the disease-eliciting allergen is a prerequisite for accurate prescription of treatment. In areas of complex sensitization to aeroallergens or in cases of hymenoptera venom allergy, the use of molecular diagnosis has demonstrated that it may lead to a change in indication and selection of allergens for immunotherapy in a large proportion of patients when compared with diagnosis based on skin prick testing and/or specific IgE determination with commercial extracts. These changes in immunotherapy prescription aided by molecular diagnosis have been demonstrated to be cost-effective in some scenarios. Certain patterns of sensitization to grass or olive pollen and bee allergens may identify patients with higher risk of adverse reaction during immunotherapy. Summary: Molecular diagnosis, when used with other tools and patients’ clinical records, can help clinicians better to select the most appropriate patients and allergens for specific immunotherapy and, in some cases, predict the risk of adverse reactions. The pattern of sensitization to allergens could potentially predict the efficacy of allergen immunotherapy provided that these immunotherapy products contain a sufficient amount of these allergens. Nevertheless, multiplex assay remains a third-level approach, not to be used as screening method in current practice.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Overall, MD can potentially improve diagnostic accuracy (specificity), distinguish cross-reactivity phenomena from true co-sensitization, resolve low-risk markers from high-risk markers of disease activity, and may improve the indication and selection of suitable allergens for AIT when compared to diagnosis based on SPT and/or sIgE determination with raw commercial extracts.980-984”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [984]
In the citing paper
“Overall, MD can potentially improve diagnostic accuracy (specificity), distinguish cross-reactivity phenomena from true co-sensitization, resolve low-risk markers from high-risk markers of disease activity, and may improve the indication and selection of suitable allergens for AIT when compared to diagnosis based on SPT and/or sIgE determination with raw commercial extracts.980-984”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [984]
In the citing paper
“Overall, MD can potentially improve diagnostic accuracy (specificity), distinguish cross-reactivity phenomena from true co-sensitization, resolve low-risk markers from high-risk markers of disease activity, and may improve the indication and selection of suitable allergens for AIT when compared to diagnosis based on SPT and/or sIgE determination with raw commercial extracts.980-984”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [984]
In the citing paper
“Overall, MD can potentially improve diagnostic accuracy (specificity), distinguish cross-reactivity phenomena from true co-sensitization, resolve low-risk markers from high-risk markers of disease activity, and may improve the indication and selection of suitable allergens for AIT when compared to diagnosis based on SPT and/or sIgE determination with raw commercial extracts.980-984”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [984]
Citations
Cites
A WAO - ARIA - GA²LEN consensus document on molecular-based allergy diagnostics
Canonica, G. W., Ansotegui, I. J., Pawankar, R., Schmid-Grendelmeier, P., van Hage, M., Baena-Cagnani, C. E., Melioli, G., Nunes, C., Passalacqua, G., Rosenwasser, L., et al. (2013) · World Allergy Organization Journal · doi:10.1186/1939-4551-6-17 · Cited by 432
Self-citationAyuso, R., Reese, G., Leong-Kee, S., Plante, M., & Lehrer, S. B. (2002) · International Archives of Allergy and Immunology · doi:10.1159/000065172 · Cited by 336
Barber, D., De La Torre, F., Feo, F., Florido, F., Guardia, P., Moreno, C., Quiralte, J., Lombardero, M., Villalba, M., Salcedo, G., et al. (2008) · Allergy · doi:10.1111/j.1398-9995.2008.01807.x · Cited by 243
Molecular diagnosis in allergy
Sastre, J. (2010) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2010.03585.x · Cited by 235 · cited 1×
“Molecular diagnosis may help to choose a more accurate immunotherapy as the major allergens rPol d 5, rVes v 5, Ves p 1, rApi m1 and Api m 10, and the cross-reactive allergen carbohydrate determinants (CCD) may help to discriminate single from double sensitization to hymenoptera venoms [1,37,38].”
BackgroundSelf-citationSastre, J., Landivar, M. E., Ruiz‐García, M., Andregnette‐Rosigno, M. V., & Mahillo, I. (2012) · Allergy · doi:10.1111/j.1398-9995.2012.02808.x · Cited by 197
Self-citationComponent resolution reveals additional major allergens in patients with honeybee venom allergy
Köhler, J., Blank, S., Müller, S., Bantleon, F., Frick, M., Huss-Marp, J., Lidholm, J., Spillner, E., & Jakob, T. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.10.060 · Cited by 177
Comparison of allergen immunotherapy practice patterns in the United States and Europe
Cox, L., & Jacobsen, L. (2009) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)60259-1 · Cited by 164
Prostatic kallikrein: A new major dog allergen
Mattsson, L., Lundgren, T., Everberg, H., Larsson, H., & Lidholm, J. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.11.021 · Cited by 161
Gámez, C., Sánchez-García, S., Ibáñez, M. D., López, R., Aguado, E., López, E., Sastre, B., Sastre, J., & del Pozo, V. (2011) · Allergy · doi:10.1111/j.1398-9995.2011.02663.x · Cited by 141
Self-citationThe performance of a component‐based allergen‐microarray in clinical practice
Wöhrl, S., Vigl, K., Zehetmayer, S., Hiller, R., Jarisch, R., Prinz, M., Stingl, G., & Kopp, T. (2006) · Allergy · doi:10.1111/j.1398-9995.2006.01078.x · Cited by 129
Research works printed but not linked: 1
- Fernández-Caldas, 2008, Mite allergens, Clin Allergy Immunol, 21, 161
Cited by
International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
Wise, S. K., Lin, S. Y., Toskala, E., Orlandi, R. R., Akdis, C. A., Alt, J. A., Azar, A., Baroody, F. M., Bachert, C., Canonica, G. W., et al. (2018) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22073 · Cited by 557
Self-citationInternational consensus statement on allergy and rhinology: Allergic rhinitis – 2023
Wise, S. K., Damask, C., Roland, L. T., Ebert, C., Levy, J. M., Lin, S., Luong, A., Rodriguez, K., Sedaghat, A. R., Toskala, E., et al. (2023) · International Forum of Allergy & Rhinology · doi:10.1002/alr.23090 · Cited by 507
Self-citationA WAO—ARIA—GA2LEN Consensus Document on Molecular-Based Allergy Diagnosis (PAMD@): Update 2020
Ansotegui, I. J., Melioli, G., Canonica, G. W., Gómez, R. M., Jensen-Jarolim, E., Ebisawa, M., Luengo, O., Caraballo, L., Passalacqua, G., Poulsen, L. K., et al. (2020) · World Allergy Organization Journal · doi:10.1016/j.waojou.2019.100091 · Cited by 122
Molecular Allergology and Its Impact in Specific Allergy Diagnosis and Therapy
Barber, D., Diaz‐Perales, A., Escribese, M. M., Kleine‐Tebbe, J., Matricardi, P. M., Ollert, M., Santos, A. F., & Sastre, J. (2021) · Allergy · doi:10.1111/all.14969 · Cited by 59
Self-citationPrecision Medicine in the Allergy Clinic: The Application of Component Resolved Diagnosis
Panaitescu, C., Haidar, L., Buzan, M. R., Grijincu, M., Spanu, D. E., Cojanu, C., Laculiceanu, A., Bumbacea, R., & Agache, I. (2022) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2022.2034501 · Cited by 13
Metadata
- Authors
- Sastre, J., & Sastre-Ibañez, M.
- Affiliations
- Allergy Department Fundación Jiménez Díaz and CIBER de Enfermedades Respiratorias (CIBERES, Institute Carlos III, Ministry of Economy and Competitiveness)
- Hospital Clínico San Carlos, Madrid, Spain
- Venue
- Current Opinion in Allergy & Clinical Immunology
- Published
- 2016-12
- Volume
- 16
- Issue
- 6
- Pages
- 565-570
- ISSN
- 1473-6322 (ISSN-L)
- 1528-4050
- OpenAlex
- W4247260172
- Cited by
- 48
- References
- 44
- Citations by year
- 2025: 2 · 2024: 2 · 2023: 4 · 2022: 9 · 2021: 8 · 2020: 1 · 2019: 7 · 2018: 3 · 2017: 1 · 2016: 11
- FWCI
- 1.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Opinion in Allergy and Clinical Immunology (publishedVersion)
- Topics
- Health Sciences › Medicine › Immunology and Allergy › Allergic Rhinitis and Sensitization
- Health Sciences › Medicine › Immunology and Allergy › Food Allergy and Anaphylaxis Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Keywords
- molecular diagnosis, allergen immunotherapy, allergen identification, aeroallergen sensitization, hymenoptera venom allergy, grass pollen allergy, olive pollen allergy, bee venom allergy, skin prick test, specific IgE, cost-effectiveness, multiplex assay, allergen selection
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Molecular diagnosis and immunotherapy. https://app.cochat.ai/papers/10.1097/aci.0000000000000318
- The paper
- Sastre, J., & Sastre-Ibañez, M. (2016). Molecular diagnosis and immunotherapy. Current Opinion in Allergy & Clinical Immunology. https://doi.org/10.1097/aci.0000000000000318
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.